Finkelstein J J
- SEC CIK
- 0001125610
No open-market purchases or sales filed in the past year.
Current role at each company
- RGRX Regenerx Biopharmaceuticals IncPresident and CEOas of May 19, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Finkelstein J J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2021 (view filing)4:35 PM ET | Jun 30 | 6 daysLate | Finkelstein J JPresident and CEO | PPurchase | +75.0K | $0.20 | +$15.0K | +4.6%1.71M after | |
| Jul 6, 2021 (view filing)4:35 PM ET | Jun 30 | 6 daysLate | Finkelstein J JPresident and CEO | PPurchase | +112.5K | $0.00 | $0 | –56.3K after | Derivative2 lots |